Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions-A Prospective Randomized Controlled Study

NCT07090525 is registered in ClinicalTrials.gov with Qingdao Central Hospital as lead sponsor.

NCT NCT07090525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions-A Prospective Randomized Controlled Study
Lead sponsor
Qingdao Central Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
July 1, 2025
Completion date
May 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overall response rate